Frazier Life Sciences Management, L.P.
Position in TRVI — Trevi Therapeutics, Inc.
CIK 1892134
PALO ALTO, CA
Position in TRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$118,578,795
-$9,869,005 QoQ
Shares Held
9,939,547
-3.1% QoQ
Ownership
7.00%
of shares outstanding
% of Portfolio
3.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Frazier Life Sciences Management, L.P. holds $3,799,191,824 across 33 Biotechnology names. TRVI ranks #10 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
7,679,684 | $709,449,207 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
16,943,774 | $542,370,205 | |
| 3 | ERAS |
Erasca, Inc.
|
24,675,188 | $399,244,541 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,448,139 | $256,058,802 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
9,874,511 | $232,643,479 | |
| 6 | MBX |
MBX Biosciences, Inc.
|
6,652,013 | $198,562,588 | |
| 7 | PHAT |
Phathom Pharmaceuticals, Inc.
|
12,466,489 | $138,502,692 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
4,567,274 | $136,333,128 |
All Filings in TRVI
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $118,578,795 | 9,939,547 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $128,447,800 | 10,259,409 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $93,873,592 | 10,259,409 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $56,118,967 | 10,259,409 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $64,531,682 | 10,259,409 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $43,938,868 | 10,664,774 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $24,652,840 | 7,381,090 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $21,995,648 | 7,381,090 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $25,464,760 | 7,381,090 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,890,660 | 7,381,090 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $15,000,776 | 6,881,090 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,445,805 | 6,881,090 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,327,641 | 6,663,590 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $12,860,728 | 6,663,590 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $8,321,528 | 5,403,590 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,292,271 | 1,171,627 | Shares | Sole | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||